Join to View Full Profile
Boston University School of Medicine72 East Concord St.Boston, MA 02118
Dr. Wolozin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Albert Einstein College of MedicineClass of 1988
Publications & Presentations
PubMed
- 20 citationsTelomere length change in a multidomain lifestyle intervention to prevent cognitive decline: a randomized clinical trialShireen Sindi, Alina Solomon, Ingemar Kåreholt, Iiris Hovatta, Riitta Antikainen
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences. 2021-02-25 - 16 citationsProtein Interaction Network Biology in Neuroscience.Avik Basu, Peter E.A. Ash, Benjamin Wolozin, Andrew Emili
Proteomics. 2021-02-01 - 4 citationsErratum: Actionable Cytopathogenic Host Responses of Human Alveolar Type 2 Cells to SARS-CoV-2 (Molecular Cell (2020) 80(6) (1104–1122.e9), (S1097276520308285), (10.10...Ryan M. Hekman, Adam J. Hume, Raghuveera Kumar Goel, Kristine M. Abo, Jessie Huang
Molecular Cell. 2021-01-07
Journal Articles
- TIA1 Regulates the Generation and Response to Toxic Tau OligomersBenjamin Wolozin, MD, Acta Neuropathologica
- RNA Binding Proteins Co-Localize with Small Tau Inclusions in TauopathyBenjamin Wolozin, MD, BioMed Central
Press Mentions
Students, Faculty, Administrators Cheer Historic Name Change, Major DonationSeptember 30th, 2022- Methylated RNA: A New Player in Tau Toxicity?September 14th, 2021
- Alzheimer’s Tau Protein Interacts with RNA to Induce NeurodegenerationAugust 30th, 2021
Grant Support
- tRNA Epitranscriptome and Translational Dysfunction in ADRDBOSTON UNIVERSITY MEDICAL CAMPUS2025–2030
- tRNA modifications regulating mitochondrial function and the mitochondrial proteome in AD/ADRDBOSTON UNIVERSITY MEDICAL CAMPUS2025–2030
- APOE Genotype Mediated Effects on Alzheimer Disease Risk and MechanismsBOSTON UNIVERSITY MEDICAL CAMPUS2024–2029
- APOE Genotype Mediated Effects on Alzheimer Disease Risk and MechanismsBOSTON UNIVERSITY MEDICAL CAMPUS2024–2029
- Development of a novel oral brain penetrant therapeutic for ALS diseaseAQUINNAH PHARMACEUTICALS, INC.2025–2027
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
